Navigation Links
Sea lice treatment increased in Norwegian fish breeding in 2009
Date:3/16/2010

Last year, increased resistance to sea lice treatments such as the pyrethroids cypermethrin and deltamethrin, as well as emamectine, was observed. Pyrethroid use still increased from 2008 to 2009, although use of emamectine reduced significantly. Older sea lice treatments are being used again due to resistance problems, e.g. azametiphos, diflubenzuron and teflubenzuron. Hydrogen peroxide, which has not been used since 1997, was also used again in 2009, mainly under controlled conditions in wellboats.

The increase in antibacterial sales from 2008-2009 was marginal and, when seen in relation to the biomass of bred fish, the usage is very low. Prescription-based statistics from the Norwegian Food Safety Authority for 2000-2008 show that antibacterials have been increasingly used in the treatment of newer breeding fish species, especially cod. For this period, the increase in the use in cod was positively correlated to the increase in biomass of cod produced. Data for sales per fish species for 2009 are not yet available.

Anthelmintics have shown an annual reduction in sales since 2004 and fungicides are back to 2008 levels.

The figures are based on sales from wholesalers to pharmacies and from feed mills to breeders.


'/>"/>

Contact: Irene Litleskare
Irene.Litleskare@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

Page: 1

Related biology news :

1. Nicotinic receptors may be important targets for treatment of multiple addictions
2. A new radiation therapy treatment developed for head and neck cancer patients
3. Restoring sight, advances in fertility treatments and better visibility for pilots at FIO
4. Presence of gene mutation helps guide thyroid cancer treatment
5. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
6. New genetic research into nicotine addiction shows promise for personalized treatment
7. Interleukin-8, key marker for colorectal cancer treatment
8. New class of drug offers hope to treatment-resistant AIDS patients
9. Paradigm shift in Alzheimerss research: new treatments
10. New research on structure of bones raises questions for treatment of osteoporosis
11. Major genetic breakthrough for ankylosing spondylitis brings treatment hope
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... LiveWire Healthcare and Life Sciences Awards as "Most ... off an unprecedented year of recognition and growth for ... over 15 years. iMedNet ™ ...
(Date:11/16/2016)... 2016 Sensory Inc ., a ... for consumer electronics, and VeriTran , a ... industry, today announced a global partnership that will ... authenticate users of mobile banking and mobile payments ... software which requires no specialized biometric scanners, yet ...
(Date:6/27/2016)... DUBLIN , June 27, 2016 Research ... in North America 2016-2020" report to their offering. ... North America to grow at a CAGR ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Biology News(10 mins):
(Date:12/9/2016)... Dec. 9, 2016 China Cord Blood Corporation (NYSE: ... China,s leading provider of cord blood collection, laboratory ... today announced the results of its 2016 Annual General Meeting, ... S.A.R., China . At ... the re-appointment of KPMG Huazhen LLP as the independent auditors ...
(Date:12/8/2016)...  The Board of Directors of the Pittsburgh ... only pure life sciences investment firm, today ... succession plan developed by the Nominating and Governance Committee ... (Jim) F. Jordan is selected to serve as ... Manzetti , who is elected to the position of ...
(Date:12/8/2016)... Dec. 8, 2016  OncoSec Medical Incorporated ("OncoSec") ... DNA-based intratumoral cancer immunotherapies, today announced financial results ... "We are delivering on our commitment to ... ImmunoPulse┬« IL-12. We are pleased with the early ... trial, and we are focused on advancing our ...
(Date:12/8/2016)... Dec. 8, 2016  Biotheranostics today announced that ... of the Breast Cancer Index (BCI) in identifying ... are most at-risk for disease recurrence and might ... from three studies advancing the understanding of the ... tumor biology and inform decisions related to patient ...
Breaking Biology Technology: